0001179110-16-018903.txt : 20160210
0001179110-16-018903.hdr.sgml : 20160210
20160210174811
ACCESSION NUMBER: 0001179110-16-018903
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20160208
FILED AS OF DATE: 20160210
DATE AS OF CHANGE: 20160210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: USANA HEALTH SCIENCES INC
CENTRAL INDEX KEY: 0000896264
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 870500306
STATE OF INCORPORATION: UT
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3838 WEST PARKWAY BLVD.
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84120-6336
BUSINESS PHONE: 8019547100
MAIL ADDRESS:
STREET 1: 3838 WEST PARKWAY BLVD.
STREET 2: 3838 WEST PARKWAY BLVD.
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84120-6336
FORMER COMPANY:
FORMER CONFORMED NAME: USANA INC
DATE OF NAME CHANGE: 19930125
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: AUCIAUX ROBERT
CENTRAL INDEX KEY: 0001203342
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35024
FILM NUMBER: 161406960
MAIL ADDRESS:
STREET 1: AV DU MANOIR 30
STREET 2: B-1410 WATERLOO
CITY: BELGIUM
STATE: C9
ZIP: 999999999
4
1
edgar.xml
FORM 4 -
X0306
4
2016-02-08
0
0000896264
USANA HEALTH SCIENCES INC
USNA
0001203342
AUCIAUX ROBERT
3838 WEST PARKWAY BLVD
SALT LAKE CITY
UT
84120
1
0
0
0
Deferred Stock Unit
2016-02-08
4
A
0
2000
A
Common Stock
2000
2000
D
Each Deferred Stock Unit ("DSU") represents the issuer's obligation to transfer one share of common stock in accordance with the terms of the deferred stock unit agreement pursuant to which the DSU's were granted.
Following termination of the undersigned's service on the issuer's Board of Directors, the issuer will distribute to the undersigned shares of common stock equal to the number of DSU's granted.
James Bramble, as attorney in fact.
2016-02-10
EX-24
2
ex24ranciaux.txt
LIMITED POWER OF ATTORNEY FOR
SECTION 16 REPORTING OBLIGATIONS
Know all by these presents, that the undersigned
hereby makes, constitutes and appoints each of Paul A. Jones and
James H. Bramble, each acting individually, as the undersigned's
true and lawful attorney-in-fact, with full power and authority
as hereinafter described on behalf of and in the name, place and
stead of the undersigned to:
(1) Prepare, execute, acknowledge, deliver and
file Forms 3, 4, 5 and 144 (including any amendments thereto)
with respect to the securities of USANA Health Sciences, Inc., a
Utah corporation (the "Company"), with the United States
Securities and Exchange Commission, any national securities
exchanges and the Company, as considered necessary or advisable
under Section 16(a) of the Securities Exchange Act of 1934 and
the rules and regulations promulgated thereunder, as amended from
time to time (the "Exchange Act");
(2) Seek or obtain, as the undersigned's
representative and on the undersigned's behalf, information on
transactions in the Company's securities from any third party,
including brokers, employee benefit plan administrators and
trustees, and the undersigned hereby authorizes any such person
to release any such information to the undersigned and approves
and ratifies any such release of information; and
(3) Perform any and all other acts which in the
discretion of such attorney-in-fact are necessary or desirable
for and on behalf of the undersigned in connection with the
foregoing.
The undersigned acknowledges that:
(1) This Power of Attorney authorizes, but does
not require, each such
attorney-in-fact to act in his or her discretion on information
provided to such attorney-in-fact without independent
verification of such information;
(2) Any documents prepared and/or executed by
either such attorney-in-fact on behalf of the undersigned
pursuant to this Power of Attorney will be in such form and will
contain such information and disclosure as such attorney-in-fact,
in his or her discretion, deems necessary or desirable;
(3) Neither the Company nor either of such
attorneys-in-fact assumes (i) any liability for the undersigned's
responsibility to comply with the requirement of the Exchange Act,
(ii) any liability of the undersigned for any failure to comply
with such requirements, or (iii) any
obligation or liability of the undersigned for profit
disgorgement under Section 16(b) of the Exchange Act; and
(4) This Power of Attorney does not relieve the
undersigned from responsibility for compliance with the
undersigned's obligations under the Exchange Act, including
without limitation the reporting requirements under Section 16 of
the Exchange Act.
The undersigned hereby gives and grants each of the
foregoing attorneys-in-fact full power and authority to do and
perform all and every act and thing whatsoever requisite,
necessary or appropriate to be done in and about the foregoing
matters as fully to all intents and purposes as the undersigned
might or could do if present, hereby ratifying all that each such
attorney-in-fact of, for and on behalf of the undersigned, shall
lawfully do or cause to be done by virtue of this Limited Power
of Attorney.
This Power of Attorney shall remain in full force and
effect until revoked by the undersigned in a signed writing
delivered to each such attorney-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of
Attorney to be executed as of this 2 day of October, 2014.
/s/ Robert Anciaux
Robert Anciaux
2